IPO Premiums
IPO calendar
APListed

Accretion Pharmaceuticals Limited

Bookbuilding IPO · NSE

Price band
₹101 - ₹101
Lot size
1,200 shares
Issue amount
₹29.75 cr
Total subscription
7.32×
Current price₹193.2
Listing price ₹79
Watch live price ↗
Opens
14 May 2025
Closes
16 May 2025
Allotment
19 May 2025
Listing
21 May 2025

Offer at a glance

Issue overview

Issue size
29,46,000 shares
Face value
₹10 per share
Minimum investment
₹1,21,200
Fresh issue
₹29.75 cr
Offer for sale
₹0 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE
Maximum investment
₹1,21,200
Issue type
Bookbuilding IPO
Shares before issue
81,70,000
Shares after issue
1,11,16,000

Lot sizes

CategoryLotsSharesAmount
RETAIL11,200₹1,21,200
HNI22,400₹2,42,400

Share reservation

RETAIL41.51%
NII(HNI)41.51%
Anchor7.17%
QIB4.81%
Market Maker5.01%

Subscription & GMP

Subscription by category

Total subscribed7.32×

Missing multiples are calculated from bids and offered shares when available.

QIB12.14×
NIB4.41×
RETAIL10.55×

GMP history

09187 May: ₹08 May: ₹09 May: ₹012 May: ₹013 May: ₹1814 May: ₹1615 May: ₹516 May: ₹017 May: ₹03 Nov: ₹012 Nov: ₹025 Nov: ₹0
7 May₹025 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
QIB—4
NIB—889
RETAIL—10,746

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs1.4317.37
RETAIL12.35130.24

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
010203040Mar-22 · Revenue: 22.6Mar-22 · Profit after tax: 0.1Mar-22Mar-23 · Revenue: 29.5Mar-23 · Profit after tax: 0.1Mar-23Mar-24 · Revenue: 33.9Mar-24 · Profit after tax: 3.9Mar-24Dec-24 · Revenue: 35.8Dec-24 · Profit after tax: 5.2Dec-24
RevenueProfit after tax

Key performance indicators

MetricDec-24Mar-24Mar-23
EPS8.749.690.26
ROE38.5472.472.7
ROCE30.1436.739.87
RONW38.5472.472.7
PRE IPO(PE)021.290
POST IPO(PE)16.0800

Values and labels as reported in the issue data.

Company information

Company profile

Accretion Pharmaceuticals Limited, founded in 2012 and based in Ahmedabad-Sanand, Gujarat, is a pharmaceutical company active in formulations and contract manufacturing with 83 employees as of January 2025. The company offers a wide range of products including tablets, capsules, syrups, ointments, creams, medicated shampoos, dusting powders, and ayurvedic wellness products, and also provides third-party manufacturing services. The proposed fund usage mainly focuses on growth capex such as facility upgrades and new machinery to increase capacity and support exports to 20+ countries, along with working capital needs, limited debt repayment, and flexibility for general purposes, helping the company scale operations, maintain quality standards, improve liquidity, and support future expansion opportunities.

Strengths

  • Experienced Leadership: Run by promoters and management with strong industry expertise.
  • Strong Relationships: Long-standing client & supplier partnerships support business stability.
  • Quality Focus: ISO-certified systems ensure high-quality pharmaceutical & healthcare products.

Risk factors

  • Ongoing Legal Cases: Current court proceedings could harm the company’s reputation and business performance.
  • Changing Regulations: Not keeping up with updated pharmaceutical laws may lead to disruptions and affect business operations.
  • Regulatory Checks: Unfavorable inspection results from authorities or clients could lead to penalties or damage the company’s image.

Promoters

Mr. Mayur Popatlal Sojitra

Mr. Harshad Nanubhai Rathod

Mr. Vivek Ashok Kumar Patel

Mr. Hardik Mukundbhai Prajapati.

Registrar & documents

Lead manager

Jawa Capital Services Private Limited

Registered office

29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand

+91-97148 82929

[email protected]Company website ↗

Frequently Asked Questions

What is Accretion Pharmaceuticals IPO GMP today?

Currently, Accretion Pharmaceuticals IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹101. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Accretion Pharmaceuticals IPO?

The minimum bid lot size for Accretion Pharmaceuticals IPO is 1,200 shares. At the cut-off price of ₹101 per share, retail investors need a minimum application amount of ₹1,21,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Accretion Pharmaceuticals IPO allotment status be announced?

The allotment status for Accretion Pharmaceuticals IPO is scheduled to be finalized on 19 May 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Accretion Pharmaceuticals IPO allotment status online by PAN?

To check Accretion Pharmaceuticals IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Accretion Pharmaceuticals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Accretion Pharmaceuticals IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums